Angiocrine BioScience, Inc.

États‑Unis d’Amérique


 
Quantité totale PI 37
Rang # Quantité totale PI 38 718
Note d'activité PI 2,3/5.0    27
Rang # Activité PI 29 402
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

7 4
10 0
12 3
1
 
Dernier brevet 2025 - Enhanced gene delivery methods
Premier brevet 2015 - Neural cells expressing adenovir...
Dernière marque 2023 - ANGIOCRINE BIOSCIENCE
Première marque 2022 - E-CELERATE

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Enhanced gene delivery methods. The present invention provides improved methods for gene deliver...
Invention Endothelial cells for treatment of gastrointestinal fistula. The present invention relates to the...
Invention Use of umbilical vein endothelial cells for the treatment of lung injury. The present invention r...
2023 Invention Methods and compositions for stem cell transplantation. The present disclosure relates to the fi...
P/S Cells for scientific, laboratory or medical research; cell growth media for growing cells for sci...
P/S Biological preparations for the treatment of damaged organs and tissue; cells for medical or cli...
P/S Cells for scientific, laboratory or medical research; cell growth media for growing cells for sc...
2022 P/S Biological preparations for the treatment of damaged organs and tissue; Cells for medical or clin...
P/S Cells for scientific, laboratory or medical research; Cell growth media for growing cells for sci...
2021 Invention Cryopreserved endothelial cell compositions. The present invention provides compositions compris...
Invention Cryopreserved endothelial cell compositions. The present invention provides compositions comprisi...
Invention Endothelial cells for mitigation of chemotherapy-induced toxicity. The present invention provide...
Invention Endothelial cells for mitigation of chemotherapy-induced toxicity. The present invention provides...
Invention Engineered endothelial cells expressing an ets transcription factor. In some aspects the present...
2020 Invention Compositions and methods for thymic regeneration and t-cell reconstitution. The present invention...
2019 Invention Compositions and methods for treatment of spinal cord injury. The present invention provides met...
Invention Compositions and methods for treatment of spinal cord injury. The present invention provides meth...
2017 Invention Blood-brain barrier comprising engineered endothelial cells. The present invention relates, in pa...
Invention Enhanced gene delivery methods. The present invention provides improved methods for gene delivery...
2016 Invention Engineered endothelial cells expressing an ets transcription factor. In some aspects the present ...
Invention Methods and compositions for stem cell transplantation. The present disclosure relates to the fie...
Invention Engineered endothelial cells expressing an e-twenty six transcription factor. In some aspects the...
2015 Invention Biocompatible implants comprising engineered endothelial cells. The present invention involves i...
Invention Biocompatible implants comprising engineered endothelial cells. The present invention involves im...
Invention Neural cells expressing adenovirus e4orf1, and methods of making and using the same. In certain a...